Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
In 2019, the market size of Needle-Free Drug Injection Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Needle-Free Drug Injection Systems.
This report studies the global market size of Needle-Free Drug Injection Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Needle-Free Drug Injection Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Market Segment by Product Type
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Market Segment by Application
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Needle-Free Drug Injection Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Needle-Free Drug Injection Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Needle-Free Drug Injection Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
In 2019, the market size of Needle-Free Drug Injection Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Needle-Free Drug Injection Systems.
This report studies the global market size of Needle-Free Drug Injection Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Needle-Free Drug Injection Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Market Segment by Product Type
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Market Segment by Application
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Needle-Free Drug Injection Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Needle-Free Drug Injection Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Needle-Free Drug Injection Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type (2019-2025)
1.3.2 Jet-Based Needle-Free Injectors
1.3.3 Spring-Based Needle-Free Injectors
1.3.4 Laser-Powered Needle-Free Injectors
1.3.5 Vibration-Based Needle-Free Injectors
1.4 Market Segment by Application
1.4.1 Global Needle-Free Drug Injection Systems Market Share by Application (2019-2025)
1.4.2 Hospitals and Clinics
1.4.3 Homecare Settings
1.4.4 Research Laboratories
1.4.5 Pharmaceutical and Biotechnology companies
1.4.6 Other End Users
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Needle-Free Drug Injection Systems Production Value 2014-2025
2.1.2 Global Needle-Free Drug Injection Systems Production 2014-2025
2.1.3 Global Needle-Free Drug Injection Systems Capacity 2014-2025
2.1.4 Global Needle-Free Drug Injection Systems Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Needle-Free Drug Injection Systems Market Size CAGR of Key Regions
2.2.2 Global Needle-Free Drug Injection Systems Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Needle-Free Drug Injection Systems Capacity by Manufacturers
3.1.2 Global Needle-Free Drug Injection Systems Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Needle-Free Drug Injection Systems Revenue by Manufacturers (2014-2019)
3.2.2 Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Needle-Free Drug Injection Systems Market Concentration Ratio (CR5 and HHI)
3.3 Needle-Free Drug Injection Systems Price by Manufacturers
3.4 Key Manufacturers Needle-Free Drug Injection Systems Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Needle-Free Drug Injection Systems Market
3.6 Key Manufacturers Needle-Free Drug Injection Systems Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Jet-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.1.2 Spring-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.1.3 Laser-Powered Needle-Free Injectors Production and Production Value (2014-2019)
4.1.4 Vibration-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.2 Global Needle-Free Drug Injection Systems Production Market Share by Type
4.3 Global Needle-Free Drug Injection Systems Production Value Market Share by Type
4.4 Needle-Free Drug Injection Systems Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Needle-Free Drug Injection Systems Consumption by Application
6 Production by Regions
6.1 Global Needle-Free Drug Injection Systems Production (History Data) by Regions 2014-2019
6.2 Global Needle-Free Drug Injection Systems Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.3.2 United States Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Needle-Free Drug Injection Systems Import & Export
6.4 European Union
6.4.1 European Union Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.4.2 European Union Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Needle-Free Drug Injection Systems Import & Export
6.5 China
6.5.1 China Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.5.2 China Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Needle-Free Drug Injection Systems Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Needle-Free Drug Injection Systems Consumption by Regions
7.1 Global Needle-Free Drug Injection Systems Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Needle-Free Drug Injection Systems Consumption by Type
7.2.2 United States Needle-Free Drug Injection Systems Consumption by Application
7.3 European Union
7.3.1 European Union Needle-Free Drug Injection Systems Consumption by Type
7.3.2 European Union Needle-Free Drug Injection Systems Consumption by Application
7.4 China
7.4.1 China Needle-Free Drug Injection Systems Consumption by Type
7.4.2 China Needle-Free Drug Injection Systems Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Needle-Free Drug Injection Systems Consumption by Type
7.5.2 Rest of World Needle-Free Drug Injection Systems Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Antares Pharma, Inc. (US)
8.1.1 Antares Pharma, Inc. (US) Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Needle-Free Drug Injection Systems
8.1.4 Needle-Free Drug Injection Systems Product Introduction
8.1.5 Antares Pharma, Inc. (US) Recent Development
8.2 Endo International plc (US)
8.2.1 Endo International plc (US) Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Needle-Free Drug Injection Systems
8.2.4 Needle-Free Drug Injection Systems Product Introduction
8.2.5 Endo International plc (US) Recent Development
8.3 PharmaJet (U.S)
8.3.1 PharmaJet (U.S) Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Needle-Free Drug Injection Systems
8.3.4 Needle-Free Drug Injection Systems Product Introduction
8.3.5 PharmaJet (U.S) Recent Development
8.4 Bioject Medical Technologies Inc. (U.S)
8.4.1 Bioject Medical Technologies Inc. (U.S) Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Needle-Free Drug Injection Systems
8.4.4 Needle-Free Drug Injection Systems Product Introduction
8.4.5 Bioject Medical Technologies Inc. (U.S) Recent Development
8.5 Medical International Technology, Inc. (U.S)
8.5.1 Medical International Technology, Inc. (U.S) Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Needle-Free Drug Injection Systems
8.5.4 Needle-Free Drug Injection Systems Product Introduction
8.5.5 Medical International Technology, Inc. (U.S) Recent Development
8.6 INJEX Pharma AG (Germany)
8.6.1 INJEX Pharma AG (Germany) Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Needle-Free Drug Injection Systems
8.6.4 Needle-Free Drug Injection Systems Product Introduction
8.6.5 INJEX Pharma AG (Germany) Recent Development
8.7 National Medical Products Inc. (US)
8.7.1 National Medical Products Inc. (US) Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Needle-Free Drug Injection Systems
8.7.4 Needle-Free Drug Injection Systems Product Introduction
8.7.5 National Medical Products Inc. (US) Recent Development
8.8 Valeritas, Inc. (US)
8.8.1 Valeritas, Inc. (US) Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Needle-Free Drug Injection Systems
8.8.4 Needle-Free Drug Injection Systems Product Introduction
8.8.5 Valeritas, Inc. (US) Recent Development
8.9 European Pharma Group (Netherland)
8.9.1 European Pharma Group (Netherland) Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Needle-Free Drug Injection Systems
8.9.4 Needle-Free Drug Injection Systems Product Introduction
8.9.5 European Pharma Group (Netherland) Recent Development
8.10 PenJet Corporation (U.S)
8.10.1 PenJet Corporation (U.S) Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Needle-Free Drug Injection Systems
8.10.4 Needle-Free Drug Injection Systems Product Introduction
8.10.5 PenJet Corporation (U.S) Recent Development
8.11 Crossject SA (France)
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Needle-Free Drug Injection Systems Capacity, Production Forecast 2019-2025
9.1.2 Global Needle-Free Drug Injection Systems Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Needle-Free Drug Injection Systems Production and Value Forecast by Regions 2019-2025
9.2.2 Global Needle-Free Drug Injection Systems Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Needle-Free Drug Injection Systems Production Forecast by Type
9.7.2 Global Needle-Free Drug Injection Systems Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Needle-Free Drug Injection Systems Sales Channels
10.2.2 Needle-Free Drug Injection Systems Distributors
10.3 Needle-Free Drug Injection Systems Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type (2019-2025)
1.3.2 Jet-Based Needle-Free Injectors
1.3.3 Spring-Based Needle-Free Injectors
1.3.4 Laser-Powered Needle-Free Injectors
1.3.5 Vibration-Based Needle-Free Injectors
1.4 Market Segment by Application
1.4.1 Global Needle-Free Drug Injection Systems Market Share by Application (2019-2025)
1.4.2 Hospitals and Clinics
1.4.3 Homecare Settings
1.4.4 Research Laboratories
1.4.5 Pharmaceutical and Biotechnology companies
1.4.6 Other End Users
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Needle-Free Drug Injection Systems Production Value 2014-2025
2.1.2 Global Needle-Free Drug Injection Systems Production 2014-2025
2.1.3 Global Needle-Free Drug Injection Systems Capacity 2014-2025
2.1.4 Global Needle-Free Drug Injection Systems Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Needle-Free Drug Injection Systems Market Size CAGR of Key Regions
2.2.2 Global Needle-Free Drug Injection Systems Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Needle-Free Drug Injection Systems Capacity by Manufacturers
3.1.2 Global Needle-Free Drug Injection Systems Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Needle-Free Drug Injection Systems Revenue by Manufacturers (2014-2019)
3.2.2 Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Needle-Free Drug Injection Systems Market Concentration Ratio (CR5 and HHI)
3.3 Needle-Free Drug Injection Systems Price by Manufacturers
3.4 Key Manufacturers Needle-Free Drug Injection Systems Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Needle-Free Drug Injection Systems Market
3.6 Key Manufacturers Needle-Free Drug Injection Systems Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Jet-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.1.2 Spring-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.1.3 Laser-Powered Needle-Free Injectors Production and Production Value (2014-2019)
4.1.4 Vibration-Based Needle-Free Injectors Production and Production Value (2014-2019)
4.2 Global Needle-Free Drug Injection Systems Production Market Share by Type
4.3 Global Needle-Free Drug Injection Systems Production Value Market Share by Type
4.4 Needle-Free Drug Injection Systems Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Needle-Free Drug Injection Systems Consumption by Application
6 Production by Regions
6.1 Global Needle-Free Drug Injection Systems Production (History Data) by Regions 2014-2019
6.2 Global Needle-Free Drug Injection Systems Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.3.2 United States Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Needle-Free Drug Injection Systems Import & Export
6.4 European Union
6.4.1 European Union Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.4.2 European Union Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Needle-Free Drug Injection Systems Import & Export
6.5 China
6.5.1 China Needle-Free Drug Injection Systems Production Growth Rate 2014-2019
6.5.2 China Needle-Free Drug Injection Systems Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Needle-Free Drug Injection Systems Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Needle-Free Drug Injection Systems Consumption by Regions
7.1 Global Needle-Free Drug Injection Systems Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Needle-Free Drug Injection Systems Consumption by Type
7.2.2 United States Needle-Free Drug Injection Systems Consumption by Application
7.3 European Union
7.3.1 European Union Needle-Free Drug Injection Systems Consumption by Type
7.3.2 European Union Needle-Free Drug Injection Systems Consumption by Application
7.4 China
7.4.1 China Needle-Free Drug Injection Systems Consumption by Type
7.4.2 China Needle-Free Drug Injection Systems Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Needle-Free Drug Injection Systems Consumption by Type
7.5.2 Rest of World Needle-Free Drug Injection Systems Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Antares Pharma, Inc. (US)
8.1.1 Antares Pharma, Inc. (US) Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Needle-Free Drug Injection Systems
8.1.4 Needle-Free Drug Injection Systems Product Introduction
8.1.5 Antares Pharma, Inc. (US) Recent Development
8.2 Endo International plc (US)
8.2.1 Endo International plc (US) Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Needle-Free Drug Injection Systems
8.2.4 Needle-Free Drug Injection Systems Product Introduction
8.2.5 Endo International plc (US) Recent Development
8.3 PharmaJet (U.S)
8.3.1 PharmaJet (U.S) Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Needle-Free Drug Injection Systems
8.3.4 Needle-Free Drug Injection Systems Product Introduction
8.3.5 PharmaJet (U.S) Recent Development
8.4 Bioject Medical Technologies Inc. (U.S)
8.4.1 Bioject Medical Technologies Inc. (U.S) Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Needle-Free Drug Injection Systems
8.4.4 Needle-Free Drug Injection Systems Product Introduction
8.4.5 Bioject Medical Technologies Inc. (U.S) Recent Development
8.5 Medical International Technology, Inc. (U.S)
8.5.1 Medical International Technology, Inc. (U.S) Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Needle-Free Drug Injection Systems
8.5.4 Needle-Free Drug Injection Systems Product Introduction
8.5.5 Medical International Technology, Inc. (U.S) Recent Development
8.6 INJEX Pharma AG (Germany)
8.6.1 INJEX Pharma AG (Germany) Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Needle-Free Drug Injection Systems
8.6.4 Needle-Free Drug Injection Systems Product Introduction
8.6.5 INJEX Pharma AG (Germany) Recent Development
8.7 National Medical Products Inc. (US)
8.7.1 National Medical Products Inc. (US) Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Needle-Free Drug Injection Systems
8.7.4 Needle-Free Drug Injection Systems Product Introduction
8.7.5 National Medical Products Inc. (US) Recent Development
8.8 Valeritas, Inc. (US)
8.8.1 Valeritas, Inc. (US) Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Needle-Free Drug Injection Systems
8.8.4 Needle-Free Drug Injection Systems Product Introduction
8.8.5 Valeritas, Inc. (US) Recent Development
8.9 European Pharma Group (Netherland)
8.9.1 European Pharma Group (Netherland) Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Needle-Free Drug Injection Systems
8.9.4 Needle-Free Drug Injection Systems Product Introduction
8.9.5 European Pharma Group (Netherland) Recent Development
8.10 PenJet Corporation (U.S)
8.10.1 PenJet Corporation (U.S) Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Needle-Free Drug Injection Systems
8.10.4 Needle-Free Drug Injection Systems Product Introduction
8.10.5 PenJet Corporation (U.S) Recent Development
8.11 Crossject SA (France)
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Needle-Free Drug Injection Systems Capacity, Production Forecast 2019-2025
9.1.2 Global Needle-Free Drug Injection Systems Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Needle-Free Drug Injection Systems Production and Value Forecast by Regions 2019-2025
9.2.2 Global Needle-Free Drug Injection Systems Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Needle-Free Drug Injection Systems Production Forecast by Type
9.7.2 Global Needle-Free Drug Injection Systems Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Needle-Free Drug Injection Systems Sales Channels
10.2.2 Needle-Free Drug Injection Systems Distributors
10.3 Needle-Free Drug Injection Systems Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
